ResMed Inc. RMD | NYSE

$237.27 $5.69 | 2.46%

After Hours
$232.75 -$4.52 | -1.91%

Next Earnings: Jan 22, 2025

Company Overview:

Market Cap: $34.83B
PE Ratio: 31.43
52-Week Range: $164.12 - $260.49
Dividend Yield (FWD): 0.89% ($2.12)

10 Year Performance Metrics:

Total Return (with DRIP): 374.62% (16.85% / yr)
Total Return (no DRIP): 345.10% (16.10% / yr)
Share Price: 317.80%
Dividend Increase: 89.29%
RMD 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

RMD Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
RMD Dividend CAGR:1Y: 10.42%2Y: 9.75%5Y: 6.33%10Y: 6.59%
Share Price
RMD Price CAGR:1Y: 36.39%2Y: 6.57%5Y: 8.76%10Y: 15.48%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

RMD Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - RMD
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - RMD
14-Day FREE Trial Get Full Access Now!

RMD Earnings, Revenue, Cash & Debt, Shares Outstaning:

RMD - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
RMD - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
RMD - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
RMD - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
RMD - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
RMD - Cash & Debt
14-Day FREE Trial Get Full Access Now!
RMD - Revenue
14-Day FREE Trial Get Full Access Now!
RMD Revenue CAGR:1Y: 27.15%2Y: 13.51%5Y: 12.45%10Y: 12.40%
RMD - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
RMD EPS CAGR:1Y: 41.61%2Y: 21.47%5Y: 20.51%10Y: 13.79%
RMD - Net Income
14-Day FREE Trial Get Full Access Now!
RMD Net Income CAGR:1Y: 41.90%2Y: 21.63%5Y: 20.98%10Y: 14.10%
RMD - EBITDA
14-Day FREE Trial Get Full Access Now!
RMD EBITDA CAGR:1Y: 53.19%2Y: 17.66%5Y: 15.54%10Y: 14.61%
RMD - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
RMD Free Cash Flow CAGR:1Y: 24.66%2Y: 398.95%5Y: 17.32%10Y: 17.03%
RMD - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
RMD Free Cash Flow / Share CAGR:1Y: 24.84%2Y: 398.21%5Y: 16.82%10Y: 16.48%
RMD - Gross Profit
14-Day FREE Trial Get Full Access Now!
RMD Gross Profit CAGR:1Y: 19.52%2Y: 15.16%5Y: 12.11%10Y: 11.69%
RMD - Expenses
14-Day FREE Trial Get Full Access Now!
RMD Expenses CAGR:1Y: -52.02%2Y: -22.18%5Y: -4.54%10Y: -1.60%
RMD - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
RMD Shares Outstanding CAGR:1Y: 0.08%2Y: 0.16%5Y: 0.34%10Y: 0.34%
RMD - Share Buybacks
14-Day FREE Trial Get Full Access Now!
RMD Share Buybacks CAGR:1Y: -52.38%2Y: 2,811.26%5Y: -38.43%10Y: 0.66%
RMD - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
RMD Stock-Based Comp CAGR:1Y: 8.89%2Y: 9.15%5Y: 8.74%10Y: 5.90%
RMD - Dividends
14-Day FREE Trial Get Full Access Now!
RMD Dividend CAGR:1Y: 10.42%2Y: 9.75%5Y: 6.33%10Y: 6.59%
RMD - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
RMD Revenue CAGR:1Y: 27.15%2Y: 13.51%5Y: 12.45%10Y: 12.40%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

RMD - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RMD Actual Revenue CAGR:1Y: 27.15%2Y: 13.51%5Y: 12.45%10Y: 12.40%
RMD - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RMD Actual EPS CAGR:1Y: 41.61%2Y: 21.47%5Y: 20.51%10Y: 13.79%
RMD - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RMD Actual Net Income CAGR:1Y: 41.90%2Y: 21.63%5Y: 20.98%10Y: 14.10%
RMD - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RMD Actual EBITDA CAGR:1Y: 53.19%2Y: 17.66%5Y: 15.54%10Y: 14.61%

Ratios, Profit Margins & Return on Capital:

RMD - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
RMD Net Profit Margin CAGR:1Y: 11.63%2Y: 7.15%5Y: 7.59%10Y: 1.51%
RMD - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
RMD Gross Profit Margin CAGR:1Y: -6.00%2Y: 1.45%5Y: -0.30%10Y: -0.63%
RMD - Price to Earnings
14-Day FREE Trial Get Full Access Now!
RMD - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
RMD - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
RMD - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

RMD Dividends Info:

Annual Dividend: $2.12
Forward Yield: 0.89%
Ex-Dividend Date: 2024-11-07
Lifetime Dividens / Share: $17.74

RMD Dividend History: Dates, Payments & Yield list

Below is a schedule of all RMD dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
11/07/202412/12/2024$0.5300.81%0.85%$248.54
08/15/202409/19/2024$0.5300.87%0.93%$227.22
05/08/202406/13/2024$0.4800.9%0.9%$212.88
02/07/202403/14/2024$0.4801.01%1.03%$186.59
11/08/202312/14/2023$0.4801.24%1.29%$148.78
08/16/202309/21/2023$0.4801.04%1.11%$173.71
05/10/202306/15/2023$0.4400.75%0.75%$233.50
02/08/202303/16/2023$0.4400.79%0.8%$220.96
11/09/202212/15/2022$0.4400.81%0.83%$211.96
08/17/202209/22/2022$0.4400.72%0.74%$236.41
05/11/202206/16/2022$0.4200.88%0.88%$191.46
02/09/202203/17/2022$0.4200.67%0.68%$246.48
11/09/202112/16/2021$0.4200.62%0.64%$261.65
08/18/202109/23/2021$0.4200.57%0.6%$279.57
05/12/202106/17/2021$0.3900.81%0.81%$192.32
02/10/202103/18/2021$0.3900.78%0.78%$200.40
11/10/202012/17/2020$0.3900.74%0.74%$212.11
08/19/202009/24/2020$0.3900.85%0.85%$183.43
05/13/202006/18/2020$0.3900.95%0.95%$164.37
02/12/202003/19/2020$0.3900.89%0.9%$172.76
11/06/201912/12/2019$0.3901.06%1.09%$143.25
08/14/201909/19/2019$0.3901.14%1.19%$131.15
05/08/201906/13/2019$0.3701.33%1.33%$111.42
02/06/201903/14/2019$0.3701.53%1.55%$95.59
11/07/201812/13/2018$0.3701.34%1.38%$107.59
08/15/201809/20/2018$0.3701.33%1.38%$107.14
05/09/201806/14/2018$0.3501.43%1.43%$98.16
02/07/201803/15/2018$0.3501.49%1.51%$92.59
11/08/201712/14/2017$0.3501.65%1.7%$82.19
08/15/201709/21/2017$0.3501.85%1.93%$72.44
05/09/201706/15/2017$0.3301.96%1.96%$67.46
02/07/201703/16/2017$0.3301.87%1.91%$68.93
11/08/201612/15/2016$0.3302.19%2.29%$57.59
08/16/201609/22/2016$0.3301.78%1.91%$69.09
05/17/201606/16/2016$0.3002.1%2.1%$57.23
02/09/201603/17/2016$0.3002.06%2.1%$57.18
11/17/201512/17/2015$0.3002.01%2.08%$57.58
08/18/201509/17/2015$0.3002.08%2.19%$54.89
05/19/201506/18/2015$0.2801.97%1.97%$56.83
02/10/201503/19/2015$0.2801.71%1.76%$63.78
11/18/201412/18/2014$0.2802.03%2.14%$52.32
08/19/201409/18/2014$0.2802%2.17%$51.53
05/16/201406/17/2014$0.2501.98%1.98%$50.57
02/14/201403/19/2014$0.2502.01%2.19%$45.74
11/15/201312/18/2013$0.2501.65%1.96%$51.05
08/16/201309/17/2013$0.2501.53%2.02%$49.52
05/17/201306/18/2013$0.1701.36%1.36%$50.07
02/14/201303/19/2013$0.1701.18%1.57%$43.18
11/16/201212/18/2012$0.1700.87%1.74%$39.10
09/05/201209/28/2012$0.1700.44%1.77%$38.45

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for RMD

Based on past 10-year performance, here are RMD growth metrics:

Share price CAGR of +15.37%
Dividend CAGR of +6.59%
Using RMD CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

RMD
Current Price$237.27
Start Shares42.15
Start Value$10,000
 
After 10 years:
Final Share Count44.94
Dividends Payment$1.00
Annual Dividends$180
Yield on cost1.80%
Share Price$859.24
Total Dividends$1,259
Final Value$38,613

Estimated Future Value + Dividends - RMD

NOTE: Above numbers are our estimate based on RMD's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

ResMed Inc. (RMD) had its IPO on 1995-06-02, and is trader on NYSE stock exchange.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

RMD website: https://www.resmed.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial